HK Stock MarketDetailed Quotes
01541 IMMUNEONCO-B
- 12.900
- +0.140+1.10%
Not Open Jul 16 16:08 CST
4.83BMarket Cap-11528P/E (TTM)
14.480High12.420Low132.40KVolume14.480Open12.760Pre Close1.68MTurnover0.06%Turnover RatioLossP/E (Static)374.16MShares32.15052wk High5.85P/B2.95BFloat Cap11.86052wk Low--Dividend TTM228.55MShs Float32.150Historical High--Dividend LFY16.14%Amplitude11.860Historical Low12.721Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
IMMUNEONCO-B Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||
| Earning before tax | 5.82%-379.46M | 19.30%-170.83M | 45.03%-402.89M | ---211.69M | -10.89%-732.95M | ---660.94M |
| Profit adjustment | ||||||
| Interest (income) - adjustment | -13.61%-10.8M | -34.09%-5.28M | -479.57%-9.51M | ---3.94M | -893.94%-1.64M | ---165K |
| Impairment and provisions: | --0 | --0 | --0 | --0 | --0 | --0 |
| Revaluation surplus: | -103.17%-1.76M | -100.58%-324K | -89.11%55.51M | --55.51M | -11.26%509.92M | --574.61M |
| -Other fair value changes | -103.17%-1.76M | -100.58%-324K | -89.11%55.51M | --55.51M | -11.26%509.92M | --574.61M |
| Asset sale loss (gain): | --0 | --0 | --0 | --0 | ---555K | --0 |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---555K | ---- |
| Depreciation and amortization: | 28.19%22.58M | 30.76%11.29M | 33.71%17.62M | --8.64M | 136.89%13.18M | --5.56M |
| -Depreciation | 28.19%22.58M | 30.76%11.29M | 33.71%17.62M | --8.64M | 136.89%13.18M | --5.56M |
| Financial expense | 93.65%1.52M | 51.44%630K | -11.67%787K | --416K | 50.76%891K | --591K |
| Exchange Loss (gain) | 99.63%-96K | 60.64%-5.8M | -386.00%-26.11M | ---14.74M | 208.17%9.13M | --2.96M |
| Special items | -27.02%75.77M | -10.57%45.46M | 191.93%103.83M | --50.83M | 392.26%35.57M | --7.23M |
| Operating profit before the change of operating capital | -12.07%-292.24M | -8.59%-124.86M | -56.65%-260.76M | ---114.98M | -137.29%-166.46M | ---70.15M |
| Change of operating capital | ||||||
| Accounts receivable (increase)decrease | 184.38%27K | 176.54%62K | -366.67%-32K | ---81K | 129.27%12K | ---41K |
| Accounts payable increase (decrease) | 30.44%6.36M | -565.59%-6.08M | -36.24%4.88M | --1.31M | 31.43%7.65M | --5.82M |
| prepayments (increase)decrease | -763.63%-67.85M | -49.33%3.91M | 156.49%10.22M | --7.72M | -2,281.45%-18.1M | ---760K |
| Cash from business operations | -43.96%-353.7M | -19.73%-126.96M | -38.89%-245.69M | ---106.04M | -171.61%-176.9M | ---65.13M |
| Special items of business | -298.51%-13.86M | -136.78%-5.4M | 151.17%6.98M | --14.67M | -422.28%-13.64M | ---2.61M |
| Net cash from operations | -53.98%-367.55M | -44.86%-132.36M | -25.28%-238.71M | ---91.37M | -181.27%-190.54M | ---67.74M |
| Cash flow from investment activities | ||||||
| Interest received - investment | 26.05%10.82M | 51.74%5.97M | 444.07%8.58M | --3.94M | 1,094.70%1.58M | --132K |
| Decrease in deposits (increase) | -617.61%-42.5M | -628.08%-43.36M | 200.00%8.21M | --8.21M | ---8.21M | ---- |
| Sale of fixed assets | ---- | --324K | ---- | ---- | --575K | ---- |
| Purchase of fixed assets | 88.41%-2.69M | 92.81%-1.35M | 4.36%-23.22M | ---18.71M | -54.57%-24.28M | ---15.71M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---84.55M | ---- |
| Recovery of cash from investments | 3,286.61%222.4M | --112M | -98.14%6.57M | ---- | 52.54%352.65M | --231.18M |
| Cash on investment | -574,747.62%-482.87M | ---112M | 99.98%-84K | ---- | -43.77%-346.48M | ---241M |
| Net cash from investment operations | -601,824.49%-294.85M | -484.86%-38.4M | 100.05%49K | ---6.57M | -328.11%-108.72M | ---25.4M |
| Net cash before financing | -177.55%-662.4M | -74.36%-170.76M | 20.25%-238.66M | ---97.94M | -221.31%-299.26M | ---93.14M |
| Cash flow from financing activities | ||||||
| New borrowing | --79.96M | --29.98M | ---- | ---- | -99.67%10K | --3M |
| Refund | ---19.98M | ---- | ---- | ---- | 99.67%-10K | ---3M |
| Issuing shares | 62.36%307.79M | ---- | -76.33%189.57M | --189.57M | 186.56%800.98M | --279.51M |
| Interest paid - financing | -93.65%-1.52M | -51.44%-630K | 11.67%-787K | ---416K | -50.76%-891K | ---591K |
| Issuance expenses and redemption of securities expenses | -705.25%-28.99M | 70.83%-736K | -57.96%-3.6M | ---2.52M | 61.95%-2.28M | ---5.99M |
| Other items of the financing business | -7.27%-6.23M | -32.15%-2.98M | -21.61%-5.8M | ---2.26M | -43.30%-4.77M | ---3.33M |
| Net cash from financing operations | 84.54%331.04M | -86.10%25.63M | -77.38%179.38M | --184.37M | 194.15%793.03M | --269.6M |
| Effect of rate | -88.02%3.14M | -60.13%5.88M | 386.98%26.17M | --14.76M | -207.31%-9.12M | ---2.97M |
| Net Cash | -458.97%-331.36M | -267.90%-145.13M | -112.01%-59.28M | --86.44M | 179.81%493.77M | --176.46M |
| Begining period cash | -4.95%635.21M | -4.95%635.21M | 263.87%668.33M | --668.33M | 1,704.80%183.67M | --10.18M |
| Cash at the end | -51.67%306.98M | -35.55%495.97M | -4.95%635.21M | --769.52M | 263.87%668.33M | --183.67M |
| Cash balance analysis | ||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg